0.00
100.00%
-10.25
Gracell Biotechnologies Inc ADR 주식(GRCL)의 최신 뉴스
Citigroup Maintains Gracell Biotechnologies Inc - ADR (GRCL) Buy Recommendation - MSN
MSN
All You Need to Know About Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Rating Upgrade to Buy - Yahoo Singapore News
Yahoo Singapore News
亘喜生物宣布正式并入阿斯利康集团
GlobeNewswire Inc.
Gracell Biotechnologies Acquisition Completed - Yahoo Finance
Yahoo Finance
AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR) - Seeking Alpha
Seeking Alpha
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
GlobeNewswire Inc.
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
GlobeNewswire Inc.
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T ... - Yahoo Finance
Yahoo Finance
AstraZeneca: Rebound in 2024 With Double-Digit Earnings Growth
Investing.com
Gracell Biotechnologies Inc. Sponsored ADR (GRCL) is a Great Momentum Stock: Should You Buy?
Zacks Investment Research
AstraZeneca (AZN) Set to Acquire Gracell for $1.2 Billion
Zacks Investment Research
Investor Sentiment Improves; Dow Jumps Over 150 Points
Benzinga
Yes Virginia, There Is a Santa Claus Rally
Zacks Investment Research
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
Benzinga
A new all-time high awaits the S&P 500 as investors 'buy into the euphoria,' says this strategist
MarketWatch
A new all-time high awaits the S&P 500 as investors 'buy into the euphoria,' says this strategist
MarketWatch
Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket
Benzinga
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs
Benzinga
A new all-time high awaits the S&P 500 as investors 'buy into the euphoria,' says this strategist
MarketWatch
Wall Street Breakfast Podcast: AstraZeneca To Buy Gracell Biotechnologies
Seeking Alpha
Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Benzinga
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and ... - GlobeNewswire
GlobeNewswire
亘喜生物宣布与阿斯利康达成收购协议,展望细胞疗法治疗癌症和自身免疫性疾病新征程
GlobeNewswire Inc.
Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
亘喜生物宣布FasTCAR-T GC012F治疗难治性系统性红斑狼疮的1/2期新药临床试验(IND)申请获中国NMPA正式批准
GlobeNewswire Inc.
Gracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023
GlobeNewswire Inc.
Wall Street Analysts Believe Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Could Rally 127.82%: Here's is How to Trade
Zacks Investment Research
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
MarketWatch
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Bitfarms And Other Big Stocks Moving Lower On Friday
Benzinga
What Makes Gracell Biotechnologies Inc. Sponsored ADR (GRCL) a Strong Momentum Stock: Buy Now?
Zacks Investment Research
Does Gracell Biotechnologies Inc. Sponsored ADR (GRCL) Have the Potential to Rally 120.94% as Wall Street Analysts Expect?
Zacks Investment Research
Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit - GlobeNewswire
GlobeNewswire
RA Capital Management, L.P. Acquires Significant Stake in Gracell Biotechnologies Inc. - Yahoo Finance
Yahoo Finance
Gracell Biotechnologies (GRCL) Surges 62% in a Week: Here's Why - Yahoo Finance
Yahoo Finance
Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed ... - PR Newswire
PR Newswire
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F at ... - PR Newswire
PR Newswire
GRCL News Today | Why did Gracell Biotechnologies stock go up today? - MarketBeat
MarketBeat
Gracell Biotechnologies Unveils Innovation Center in U.S. - PR Newswire
PR Newswire
GRCL News Today | Why did Gracell Biotechnologies stock go up today? - MarketBeat
MarketBeat
Gracell Biotechnologies (GRCL) Stock Price, News & Analysis - MarketBeat
MarketBeat
Gracell Biotechnologies Announces Pricing of Initial Public Offering - PR Newswire
PR Newswire
자본화:
|
볼륨(24시간):